This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

APO-ROSUVASTATIN

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-ROSUVASTATIN in Canada?

Yes. APO-ROSUVASTATIN 5MG has an active shortage reported to Health Canada (last updated September 25, 2026).

Why is APO-ROSUVASTATIN not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-ROSUVASTATIN be available again?

The manufacturer's estimated resolution date is December 4, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file6 products

Affected strength5MG

Last updated2018-09-15

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

IPG-ROSUVASTATIN

MARCAN PHARMACEUTICALS INC

5MG · DIN 02410931

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

BIO-ROSUVASTATIN

BIOMED PHARMA

5MG · DIN 02444968

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ACH-ROSUVASTATIN

ACCORD HEALTHCARE INC

20MG · DIN 02438933

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

ROSUVASTATIN

COBALT PHARMACEUTICALS COMPANY

20MG · DIN 02433141

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

NTP-ROSUVASTATIN

TEVA CANADA LIMITED

40MG · DIN 02385554

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

Q-ROSUVASTATIN

QD PHARMACEUTICALS ULC

10.0MG · DIN 02390523

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02337975

Strength

5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ROSUVASTATIN

Tier

Unrated

Last Updated

2018-09-15

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-ROSUVASTATIN has 3 shortage/discontinuation reports on file — this is one of them.

2026-09-25

Active Shortage

Disruption of the manufacture of the drug.

2026-09-18

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244